Cargando…
Radiotherapy as an immune checkpoint blockade combination strategy for hepatocellular carcinoma
In the immune oncology era, the clinical efficacy of immune checkpoint inhibitors (ICIs) against most solid cancers is well known. In hepatocellular carcinoma, the recent success of combination therapy with targeting agents has accelerated the search for novel combination strategies. Radiotherapy (R...
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Baishideng Publishing Group Inc
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7968135/ https://www.ncbi.nlm.nih.gov/pubmed/33776363 http://dx.doi.org/10.3748/wjg.v27.i10.919 |